Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

The metabolic fate of fenclozic acid in chimeric mice with a humanized liver.

Ekdahl A, Weidolf L, Baginski M, Morikawa Y, Thompson RA, Wilson ID.

Arch Toxicol. 2018 Aug 9. doi: 10.1007/s00204-018-2274-0. [Epub ahead of print]

PMID:
30094548
2.

Functional Status Change Among Children With Extracorporeal Membrane Oxygenation to Support Cardiopulmonary Resuscitation in a Pediatric Cardiac ICU: A Single Institution Report.

Beshish AG, Baginski MR, Johnson TJ, Deatrick BK, Barbaro RP, Owens GE.

Pediatr Crit Care Med. 2018 Jul;19(7):665-671. doi: 10.1097/PCC.0000000000001555.

PMID:
29659415
3.

Cell Density-Dependent Cytological Stage Profile and Its Application for a Screen of Cytostatic Agents Active Toward Leukemic Stem Cells.

Lica JJ, Grabe GJ, Heldt M, Misiak M, Bloch P, Serocki M, Switalska M, Wietrzyk J, Baginski M, Hellmann A, Borowski E, Skladanowski A.

Stem Cells Dev. 2018 Apr 1;27(7):488-513. doi: 10.1089/scd.2017.0245. Epub 2018 Mar 13.

PMID:
29431006
4.

The structurally similar TRFH domain of TRF1 and TRF2 dimers shows distinct behaviour towards TIN2.

Kalathiya U, Padariya M, Baginski M.

Arch Biochem Biophys. 2018 Mar 15;642:52-62. doi: 10.1016/j.abb.2018.02.005. Epub 2018 Feb 8.

PMID:
29428209
5.

Extracting functional groups of ALLINI to design derivatives of FDA-approved drugs: Inhibition of HIV-1 integrase.

Kalathiya U, Padariya M, Baginski M.

Biotechnol Appl Biochem. 2018 Feb 6. doi: 10.1002/bab.1646. [Epub ahead of print]

PMID:
29405478
6.

Novel (S)-1,3,4,12a-tetrahydropyrazino[2,1-c][1,4]benzodiazepine-6,12(2H,11H)-dione derivatives: Selective inhibition of MV-4-11 biphenotypic B myelomonocytic leukemia cells' growth is accompanied by reactive oxygen species overproduction and apoptosis.

Mieczkowski A, Psurski M, Bagiński M, Bieszczad B, Mroczkowska M, Wilczek M, Czajkowska J, Trzybiński D, Woźniak K, Wietrzyk J.

Bioorg Med Chem Lett. 2018 Feb 15;28(4):618-625. doi: 10.1016/j.bmcl.2018.01.034. Epub 2018 Jan 31.

PMID:
29395971
7.

Structural and dynamic insights on the EmrE protein with TPP+ and related substrates through molecular dynamics simulations.

Padariya M, Kalathiya U, Baginski M.

Chem Phys Lipids. 2018 May;212:1-11. doi: 10.1016/j.chemphyslip.2017.12.004. Epub 2017 Dec 27.

PMID:
29288640
8.

Molecular basis for the DNA damage induction and anticancer activity of asymmetrically substituted anthrapyridazone PDZ-7.

Misiak M, Heldt M, Szeligowska M, Mazzini S, Scaglioni L, Grabe GJ, Serocki M, Lica J, Switalska M, Wietrzyk J, Beretta GL, Perego P, Zietkowski D, Baginski M, Borowski E, Skladanowski A.

Oncotarget. 2017 Oct 10;8(62):105137-105154. doi: 10.18632/oncotarget.21806. eCollection 2017 Dec 1.

9.

Molecular basis and potential activity of HIV-1 reverse transcriptase toward trimethylamine-based compounds.

Padariya M, Kalathiya U, Baginski M.

Biotechnol Appl Biochem. 2017 Nov;64(6):810-826. doi: 10.1002/bab.1543. Epub 2017 May 17.

PMID:
27859659
10.

Use of Low-Fidelity Simulation Within a Medication Calculation Nursing Course to Enhance Students' Understanding of Accuracy.

Baginski MN.

Nurse Educ. 2017 May/Jun;42(3):110-111. doi: 10.1097/NNE.0000000000000334. No abstract available.

PMID:
27723685
11.

Molecular basis and quantitative assessment of TRF1 and TRF2 protein interactions with TIN2 and Apollo peptides.

Kalathiya U, Padariya M, Baginski M.

Eur Biophys J. 2017 Mar;46(2):171-187. doi: 10.1007/s00249-016-1157-7. Epub 2016 Jul 22.

PMID:
27450562
12.

Membrane Sterols Modulate the Binding Mode of Amphotericin B without Affecting Its Affinity for a Lipid Bilayer.

Neumann A, Wieczor M, Zielinska J, Baginski M, Czub J.

Langmuir. 2016 Apr 12;32(14):3452-61. doi: 10.1021/acs.langmuir.5b04433. Epub 2016 Mar 30.

PMID:
27007267
13.

Molecular Modeling and Evaluation of Novel Dibenzopyrrole Derivatives as Telomerase Inhibitors and Potential Drug for Cancer Therapy.

Kalathiya U, Padariya M, Baginski M.

IEEE/ACM Trans Comput Biol Bioinform. 2014 Nov-Dec;11(6):1196-207. doi: 10.1109/TCBB.2014.2326860.

PMID:
26357055
14.

Identification of 1H-indene-(1,3,5,6)-tetrol derivatives as potent pancreatic lipase inhibitors using molecular docking and molecular dynamics approach.

Kalathiya U, Padariya M, Baginski M.

Biotechnol Appl Biochem. 2016 Nov;63(6):765-778. doi: 10.1002/bab.1432. Epub 2015 Sep 24.

PMID:
26265531
15.

Structural and dynamic changes adopted by EmrE, multidrug transporter protein--Studies by molecular dynamics simulation.

Padariya M, Kalathiya U, Baginski M.

Biochim Biophys Acta. 2015 Oct;1848(10 Pt A):2065-74. doi: 10.1016/j.bbamem.2015.05.014. Epub 2015 May 23.

16.

Interaction of cisplatin and two potential antitumoral platinum(II) complexes with a model lipid membrane: a combined NMR and MD study.

Nierzwicki L, Wieczor M, Censi V, Baginski M, Calucci L, Samaritani S, Czub J, Forte C.

Phys Chem Chem Phys. 2015 Jan 14;17(2):1458-68. doi: 10.1039/c4cp04360j. Epub 2014 Nov 28.

PMID:
25429970
17.
18.

The effect of sterols on amphotericin B self-aggregation in a lipid bilayer as revealed by free energy simulations.

Neumann A, Baginski M, Winczewski S, Czub J.

Biophys J. 2013 Apr 2;104(7):1485-94. doi: 10.1016/j.bpj.2013.02.029.

19.

How do sterols determine the antifungal activity of amphotericin B? Free energy of binding between the drug and its membrane targets.

Neumann A, Baginski M, Czub J.

J Am Chem Soc. 2010 Dec 29;132(51):18266-72. doi: 10.1021/ja1074344. Epub 2010 Dec 2.

PMID:
21126070
20.

On the possibility of the amphotericin B-sterol complex formation in cholesterol- and ergosterol-containing lipid bilayers: a molecular dynamics study.

Neumann A, Czub J, Baginski M.

J Phys Chem B. 2009 Dec 3;113(48):15875-85. doi: 10.1021/jp905133f.

PMID:
19929013
21.

Amphotericin B and its new derivatives - mode of action.

Baginski M, Czub J.

Curr Drug Metab. 2009 Jun;10(5):459-69. Review.

PMID:
19689243
22.

Influence of a lipid bilayer on the conformational behavior of amphotericin B derivatives - A molecular dynamics study.

Czub J, Neumann A, Borowski E, Baginski M.

Biophys Chem. 2009 Apr;141(1):105-16. doi: 10.1016/j.bpc.2009.01.001. Epub 2009 Jan 9.

PMID:
19185412
23.

Interactions of amphotericin B derivatives with lipid membranes--a molecular dynamics study.

Czub J, Borowski E, Baginski M.

Biochim Biophys Acta. 2007 Oct;1768(10):2616-26. Epub 2007 Jun 23.

24.

Interaction of amphotericin B and its selected derivatives with membranes: molecular modeling studies.

Baginski M, Czub J, Sternal K.

Chem Rec. 2006;6(6):320-32. Review.

PMID:
17304519
25.
26.

Comparative molecular dynamics study of lipid membranes containing cholesterol and ergosterol.

Czub J, Baginski M.

Biophys J. 2006 Apr 1;90(7):2368-82. Epub 2006 Jan 6.

27.

Thermodynamic and electrostatic properties of ternary Oxytricha nova TEBP-DNA complex.

Wojciechowski M, Fogolari F, Baginski M.

J Struct Biol. 2005 Dec;152(3):169-84. Epub 2005 Nov 14.

PMID:
16314111
28.

Induction of unique structural changes in guanine-rich DNA regions by the triazoloacridone C-1305, a topoisomerase II inhibitor with antitumor activities.

Lemke K, Wojciechowski M, Laine W, Bailly C, Colson P, Baginski M, Larsen AK, Skladanowski A.

Nucleic Acids Res. 2005 Oct 27;33(18):6034-47. Print 2005.

29.

Molecular modelling of membrane activity of amphotericin B, a polyene macrolide antifungal antibiotic.

Baginski M, Sternal K, Czub J, Borowski E.

Acta Biochim Pol. 2005;52(3):655-8. Epub 2005 Aug 5. Review.

30.

MM/PBSA analysis of molecular dynamics simulations of bovine beta-lactoglobulin: free energy gradients in conformational transitions?

Fogolari F, Moroni E, Wojciechowski M, Baginski M, Ragona L, Molinari H.

Proteins. 2005 Apr 1;59(1):91-103.

PMID:
15690343
31.

Molecular aspects of the interaction between amphotericin B and a phospholipid bilayer: molecular dynamics studies.

Sternal K, Czub J, Baginski M.

J Mol Model. 2004 Jun;10(3):223-32. Epub 2004 Apr 30.

PMID:
15118877
32.

Comparative molecular dynamics simulations of amphotericin B-cholesterol/ergosterol membrane channels.

Baginski M, Resat H, Borowski E.

Biochim Biophys Acta. 2002 Dec 23;1567(1-2):63-78.

33.

Ion passage pathways and thermodynamics of the amphotericin B membrane channel.

Resat H, Baginski M.

Eur Biophys J. 2002 Jul;31(4):294-305. Epub 2002 Apr 13.

PMID:
12122476
34.

Binding free energy of selected anticancer compounds to DNA--theoretical calculations.

Baginski M, Polucci P, Antonini I, Martelli S.

J Mol Model. 2002 Jan;8(1):24-32.

PMID:
12111399
35.

Conformational properties of amphotericin B amide derivatives--impact on selective toxicity.

Resat H, Sungur FA, Baginski M, Borowski E, Aviyente V.

J Comput Aided Mol Des. 2000 Oct;14(7):689-703.

PMID:
11008890
36.
37.

Molecular properties of amphotericin B membrane channel: a molecular dynamics simulation.

Baginski M, Resat H, McCammon JA.

Mol Pharmacol. 1997 Oct;52(4):560-70.

38.

Conformational analysis of Amphotericin B.

Baginski M, Gariboldi P, Bruni P, Borowski E.

Biophys Chem. 1997 Apr 22;65(2-3):91-100.

PMID:
17029848
39.

The role of amphotericin B amino group basicity in its antifungal action. A theoretical approach.

Bagiński M, Gariboldi P, Borowski E.

Biophys Chem. 1994 Apr;49(3):241-50.

PMID:
8018821
40.

Comparative conformational analysis of cholesterol and ergosterol by molecular mechanics.

Bagiński M, Tempczyk A, Borowski E.

Eur Biophys J. 1989;17(3):159-66.

PMID:
2792025
41.

[Some biochemical parameters of sputum from patients with chronic bronchitis depending on the presence of bronchial spasm].

Bednarski W, Kossmann S, Pilarek M, Bagiński M.

Pneumonol Pol. 1976 Nov-Dec;44(11-12):1015-9. Polish. No abstract available.

PMID:
1005154

Supplemental Content

Loading ...
Support Center